View Cart  

Minimization, Omission of Risk Info Increasingly Found in Drug Promos

Drug and medical device companies increasingly are minimizing or omitting the risks associated with their products in advertising and promotional materials, an FDA official says.

To View This Article:


Subscribe To The Executive Briefing Series

Buy This Article Now

Add this article to your cart for $40.00